ArticleEuropean journal of clinical pharmacology2024

Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system.

Bo Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.